Journal article icon

Journal article

Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSA

Abstract:

Objectives: The objectives of this study were to estimate the relative transmissibility of mupirocin-resistant (MupR) and mupirocin-susceptible (MupS) MRSA strains and evaluate the long-term impact of MupR on MRSA control policies.

Methods: Parameters describing MupR and MupS strains were estimated using Markov chain Monte Carlo methods applied to data from two London teaching hospitals. These estimates parameterized a model used to evaluate the long-term impact of MupR on three mupirocin usage policies: 'clinical cases', 'screen and treat' and 'universal'. Strategies were assessed in terms of colonized and infected patient days and scenario and sensitivity analyses were performed.

Results: The transmission probability of a MupS strain was 2.16 (95% CI 1.38–2.94) times that of a MupR strain in the absence of mupirocin usage. The total prevalence of MupR in colonized and infected MRSA patients after 5 years of simulation was 9.1% (95% CI 8.7%–9.6%) with the 'screen and treat' mupirocin policy, increasing to 21.3% (95% CI 20.9%–21.7%) with 'universal' mupirocin use. The prevalence of MupR increased in 50%–75% of simulations with 'universal' usage and .10% of simulations with 'screen and treat' usage in scenarios where MupS had a higher transmission probability than MupR.

Conclusions: Our results provide evidence from a clinical setting of a fitness cost associated with MupR in MRSA strains. This provides a plausible explanation for the low levels of mupirocin resistance seen following 'screen and treat' mupirocin usage. From our simulations, even under conservative estimates of relative transmissibility, we see long-term increases in the prevalence of MupR given 'universal' use.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1093/jac/dkv249

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author

Contributors


More from this funder
Funding agency for:
Cooper, B
Grant:
MR/K006924/1


Publisher:
Oxford University Press
Journal:
Journal of Antimicrobial Chemotherapy More from this journal
Volume:
70
Issue:
12
Pages:
3366–3378
Publication date:
2015-09-03
DOI:
EISSN:
1460-2091
ISSN:
0305-7453


Pubs id:
pubs:571672
UUID:
uuid:ea56d197-7afa-48a7-affc-45f2ecafc9cb
Local pid:
pubs:571672
Source identifiers:
571672
Deposit date:
2015-10-29
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP